Zobrazeno 1 - 10
of 15
pro vyhledávání: '"M J. M. L. Gilmore"'
Autor:
Jane F. Apperley, P. J. Gravett, George Janossy, K. Ivory, D. Wardle, JohnM. Goldman, Almalina Bacigalupo, A. A. G. Robertson, H. G. Prentice, I. Mcvickei, Hilary A. Blacklock, C. Pearson, Christopher M. Reid, I. M. Hann, M. J. M. L. Gilmore, A. V. Hoffbrand, M. Alcorn, Alan Kenneth Burnett, J. Lord, J. Patterson, D. Skeggs, Malcolm K. Brenner, H. Morgan, John G. Gribben
Publikováno v:
British Journal of Haematology. 63:221-230
Bone marrow graft rejection following HLA-matched bone marrow transplantation (BMT) for leukaemia has been a rare problem. However, with the introduction of T-lymphocyte depleted BMT, graft rejection is recognized as a new complication. At the Royal
Publikováno v:
Cytokines in Hemopoiesis, Oncology, and AIDS II ISBN: 9783540552420
Ex vivo treatment of bone marrow with haematopoietic growth factors may prove to be a useful method for priming haematopoietic cells prior to autologous and allogeneic transplantation. This approach may reduce the period of post-transplant aplasia [1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15c81851b08b0ef3ec04f0e8212dbc7f
https://doi.org/10.1007/978-3-642-48715-6_6
https://doi.org/10.1007/978-3-642-48715-6_6
Autor:
M. J. M. L. Gilmore, H. G. Prentice
Publikováno v:
Vox Sanguinis. 51:202-206
Allogeneic bone marrow transplantation has been undertaken within this centre on 62 patients with acute or chronic leukaemia. Employing the standard separation protocol described, all bone marrows were processed on the 2991 Blood Cell Processor to is
Autor:
S. Graphakos, Hilary A. Blacklock, D. Skeggs, M. J. M. L. Gilmore, J. Patterson, H. G. Prentice, A. V. Hoffbrand, N. Tidman, L. Price-Jones, George Janossy, K. Ivory, S. Ball, L.K. Trejdosiewicz, D. D. Panjwani
Publikováno v:
The Lancet. 323:472-476
For more than 15 years preclinical studies have suggested that acute graft-versus-host disease (aGvHD) might be prevented by the removal of immunocompetent T lymphocytes from the donor marrow inoculum. To test this observation in man 14 patients were
Autor:
K. Ivory, S. Graphakos, M. J. M. L. Gilmore, A. V. Hoffbrand, H. G. Prentice, J. Patterson, Malcolm K. Brenner, George Janossy
Publikováno v:
British Journal of Haematology. 64:69-75
Summary. The IBM 2991 Blood Cell Processor has been used to isolate a mononuclear cell (MNC) fraction from the marrow of 31 allogeneic donors. The MNC fraction was then incubated with a combination of two murine monoclonal antibodies MBG6 (CD6) and R
Autor:
M. J. M. L. Gilmore, H. G. Prentice, H. A. Blacklock, George Janossy, A. V. Hoffbrand, K. Ivory
Publikováno v:
Medical Oncology and Tumor Pharmacotherapy. 1:279-284
We have previously reported that the elimination of T-lymphocytes (greater than 99%) from the donor bone marrow prevents significant graft versus host disease (GvHD). This has been confirmed by other centres. Many of these groups have applied monoclo
Autor:
M. J. M. L. Gilmore, C.B.T Knight, G. Hazlehurst, J.P.M Evans, David D.F. Ma, A. V. Hoffbrand, H. G. Prentice, Hilary A. Blacklock
Publikováno v:
The Lancet. 320:1061-1064
Eight patients with acute leukaemia undergoing allogeneic bone-marrow transplantation from ABO-incompatible donors received red-cell-depleted donor marrow without any procedure to diminish their anti-ABO antibody titres. Successful marrow red-cell re
Autor:
George Janossy, S. Schey, H. G. Prentice, G. Goldstein, E. Price Jones, M. J. M. L. Gilmore, N Tidman, H. A. Blacklock, A. V. Hoffbrand
Publikováno v:
British journal of haematology. 55(4)
Marrow nucleated cells from eight normal allogeneic donors was layered on Ficoll-Metrizoate to isolate the mononuclear cell fraction. The cells were then washed to remove Ficoll-Metrizoate and coagulation factors prior to resuspension in a balanced s
Autor:
A. A. G. Robertson, Jane F. Apperley, H. G. Prentice, John G. Gribben, D. Skeggs, Malcolm K. Brenner, George Janossy, JohnM. Goldman, K. Ivory, J. Patterson, M. J. M. L. Gilmore, I. M. Hann, M. Alcorn, Alan Kenneth Burnett, C. Pearson, Almalina Bacigalupo, Christopher M. Reid, H. A. Blacklock, A. V. Hoffbrand, I. McVickers, D. Wardle
Publikováno v:
11th Annual meeting of the EBMT ISBN: 9783662393994
In February 1984 a collaborative trial was begun using the Royal Free (RF) cocktail of MBG6 and RFT8 monoclonal antibodies to T-deplete donor marrow for allogeneic BMT for leukaemia. The trial followed the successful use of the cocktail in 25 patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c38af8f531887bf9b9c16f8fe77b0df
https://doi.org/10.1007/978-3-662-40457-7_93
https://doi.org/10.1007/978-3-662-40457-7_93
Autor:
J. Z. Wimperis, George Janossy, J. K. Pattinson, A. Thomas, J.-P. Grob, N. Bell, John F. Hancock, H. G. Prentice, A. V. Hoffbrand, M. J. M. L. Gilmore, D. Skeggs, Malcolm K. Brenner, J. Patterson
Publikováno v:
Minimal Residual Disease in Acute Leukemia 1986 ISBN: 9789401083980
Since May 1983 and following the institution of our present studies of “total” T-lymphocyte depletion for graft versus host disease (GvHD) prevention we have transplanted 22 patients in first complete remission (1st CR) of acute leukaemia using H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9adbdfb1c5cf9a58149730b1e3a5b370
https://doi.org/10.1007/978-94-009-4273-8_30
https://doi.org/10.1007/978-94-009-4273-8_30